Related references
Note: Only part of the references are listed.Increased eGFR with telbivudine in combination therapy of chronic hepatitis B infection
Deepak Amarapurkar et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2014)
Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up
Claudie Laprise et al.
CLINICAL INFECTIOUS DISEASES (2013)
Renal side effects of adefovir in hepatitis B virus-(HBV) positive kidney allograft recipients
N. Kamar et al.
CLINICAL NEPHROLOGY (2013)
Adefovir treatment for chronic hepatitis B in heart transplant recipients
Emanuele Durante-Mangoni et al.
CLINICAL TRANSPLANTATION (2013)
Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B
Y. Wang et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Why do I treat HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues?
George V. Papatheodoridis
LIVER INTERNATIONAL (2013)
52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B
Teerha Piratvisuth et al.
PLOS ONE (2013)
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B
N. Gara et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
Robert G. Gish et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naive patients with HBV-related decompensated cirrhosis
H. L. Y. Chan et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation
E. Cholongitas et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis
Xiao-Yong Zheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy
Yong-Feng Yang et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2012)
Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains
In O. Sun et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2012)
Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
Andrew M. Hall et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection
Akihiko Numata et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Long-term (7-year-) treatment with lamivudine monotherapy in HBV-associated glomerulonephritis
M. Mesquita et al.
CLINICAL NEPHROLOGY (2011)
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B
E. Jenny Heathcote et al.
GASTROENTEROLOGY (2011)
Hypophosphataemic Osteomalacia in Patients on Adefovir Dipivoxil
Christian M. Girgis et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Efficacy and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B and Renal Impairment
Mitchell L. Shiffman et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
Stefan Mauss et al.
JOURNAL OF HEPATOLOGY (2011)
Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients
Spilios Manolakopoulos et al.
LIVER INTERNATIONAL (2011)
Focal segmental glomerulosclerosis as a complication of hepatitis B virus infection
Kentaro Sakai et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis B
Pietro Lampertico et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Tenofovir Therapy in Hepatitis B Virus-Positive Solid-Organ Transplant Recipients
Mathieu Daude et al.
TRANSPLANTATION (2011)
Response to adefovir or entecavir in renal allograft recipients with hepatitic flare due to lamivudine-resistant hepatitis B
Kai Chung Tse et al.
CLINICAL TRANSPLANTATION (2010)
Entecavir Treatment for Chronic Hepatitis B Infection in End-Stage Renal Disease and Kidney Transplantation
Ezequiel Ridruejo et al.
DIALYSIS & TRANSPLANTATION (2010)
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
Florian van Boemmel et al.
HEPATOLOGY (2010)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
HEPATITIS B VIRUS-RELATED MEMBRANOUS NEPHROPATHY TREATED WITH ENTECAVIR
Ryota Ikee et al.
NEPHROLOGY (2010)
Evaluation of Adult Kidney Transplant Candidates
Phuong-Thu Pham et al.
SEMINARS IN DIALYSIS (2010)
Long-Term Outcome of Renal Transplant Recipients With Chronic Hepatitis B Infection-Impact of Antiviral Treatments
Desmond Y. H. Yap et al.
TRANSPLANTATION (2010)
Kidney Transplantation from Hepatitis B Surface Antigen Positive Donors into Hepatitis B Surface Antibody Positive Recipients: A Prospective Nonrandomized Controlled Study from a Single Center
H. Jiang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B
Yun-Fan Liaw et al.
GASTROENTEROLOGY (2009)
Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil
Nghi B. Ha et al.
HEPATOLOGY (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Impact of Hepatitis B and C Virus Infections on Kidney Transplantation: A Single Center Experience
L. Santos et al.
TRANSPLANTATION PROCEEDINGS (2009)
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
George V. Popotheodoridis et al.
LANCET INFECTIOUS DISEASES (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatitis B Virus Infection and the Dialysis Patient
Fabrizio Fabrizi et al.
SEMINARS IN DIALYSIS (2008)
Entecavir therapy for adefovir-resistant hepatitis B virus infection in kidney and liver allograft recipients
Nassim Kamar et al.
TRANSPLANTATION (2008)
Telbivudine versus lamivudine in patients with chronic hepatitis B
Ching-Lung Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy
Tang-Wei Chuang et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2007)
Prophylaxis and treatment of hepatitis B in immunocompromised patients
A. Marzano et al.
DIGESTIVE AND LIVER DISEASE (2007)
Navigating the maze of hepatitis B treatments
Anna Suk-Fong Lok
GASTROENTEROLOGY (2007)
Hepatitis B treatment: Lessons for the nephrologist
S. K. Olsen et al.
KIDNEY INTERNATIONAL (2006)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with adefovir dipivoxil: Premiminary results
H. J. de Silva et al.
TRANSPLANTATION PROCEEDINGS (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Tenofovir-associated acute and chronic kidney disease: A case of multiple drug interactions
AE Zimmermann et al.
CLINICAL INFECTIOUS DISEASES (2006)
Kidney transplantation from anti-HBc+ donors:: Results from a retrospective Italian study
TM De Feo et al.
TRANSPLANTATION (2006)
Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment
Brian P. Kearney et al.
CLINICAL PHARMACOKINETICS (2006)
The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome
I Berber et al.
TRANSPLANTATION PROCEEDINGS (2005)
HBsAg seropositive status and survival after renal transplantation: Meta-analysis of observational studies
F Fabrizi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infection
JB Gornals et al.
TRANSPLANTATION PROCEEDINGS (2005)
Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency
HL Fontaine et al.
TRANSPLANTATION (2005)
Lamivudine in hepatitis B-associated membranous nephropathy
S Tang et al.
KIDNEY INTERNATIONAL (2005)
Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis B infection
SI Gan et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Hepatitis B virus-associated polyarteritis Nodosa - Clinical characteristics, outcome, and impact of treatment in 115 patients
L Guillevin et al.
MEDICINE (2005)
Use of hepatitis B core anti body-positive donor kidneys in hepatitis B surface antibody-positive and -negative recipients
M Veroux et al.
TRANSPLANTATION PROCEEDINGS (2005)
Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation
E Akalin et al.
CLINICAL TRANSPLANTATION (2005)
Long-term renal safety of tenofovir disoproxil fumurate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study
H Izzedine et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection
A Garcia et al.
TRANSPLANTATION PROCEEDINGS (2005)
Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation
Tadeusz Wojciech Lapinski et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: Meta-analysis of clinical trials
F Fabrizi et al.
TRANSPLANTATION (2004)
Transjugular liver biopsy in patients with end-stage renal disease
A Ahmad et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2004)
Current management of chronic hepatitis B
GV Papatheodoridis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
MG Peters et al.
GASTROENTEROLOGY (2004)
Hepatitis B virus-associated nephropathy
R Bhimma et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Role of hepatitis B virus infection in pathogenesis of IgA nephropathy
NS Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Pharmacokinetics of tenofovir in haemodialysis
H Izzedine et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Excellent outcome of lamivudine treatment in patients with chronic renal failure and hepatitis B virus infection
H Schmilovitz-Weiss et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
Drug-induced renal failure: Update on new medications and unique mechanisms of nephrotoxicity
MA Perazella
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
SJ Hadziyannis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency
HL Tillmann et al.
LIVER TRANSPLANTATION (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Acute humoral rejection in hepatitis C-infected transplant recipients receiving antiviral therapy
S Baid et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients
TM Chan et al.
HEPATOLOGY (2002)
Lamivudine in renal transplant candidates with chronic hepatitis B infection
S Boyacioglu et al.
TRANSPLANTATION PROCEEDINGS (2002)
Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease
GV Papatheodoridis et al.
HEPATOLOGY (2002)
Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs
T Cihlar et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2001)
An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation
Z Ben-Ari et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2000)
HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients
H Fontaine et al.
TRANSPLANTATION (2000)
Share Paper
